NASDAQ:NDRA ENDRA Life Sciences (NDRA) Stock Price, News & Analysis → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free NDRA Stock Alerts $0.32 +0.02 (+6.60%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range$0.30▼$0.3350-Day Range$0.23▼$1.2152-Week Range$0.22▼$2.79Volume25,130 shsAverage Volume157,578 shsMarket Capitalization$3.57 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get ENDRA Life Sciences alerts: Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About ENDRA Life Sciences Stock (NASDAQ:NDRA)ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.Read More NDRA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NDRA Stock News HeadlinesMay 7, 2024 | finance.yahoo.comENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024May 7, 2024 | bizjournals.comLife sciences firm picks Triangle over Boston, Philly for 170-job facilityMay 9, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.May 2, 2024 | finanznachrichten.deENDRA Life Sciences Inc.: ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International PatentsMay 2, 2024 | msn.comLife's insiders: Decoding endosymbiosis with mathematicsMay 2, 2024 | businesswire.comENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International PatentsApril 26, 2024 | reuters.comIndia's Glenmark Life Sciences posts lower Q4 profit as Red Sea crisis hurts API businessApril 12, 2024 | markets.businessinsider.comIRA Capital Acquires 237,000 Square-Foot Life Science/R&D Campus in ColumbusMay 9, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.April 1, 2024 | finance.yahoo.comENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call TranscriptMarch 29, 2024 | finance.yahoo.comQ4 2023 ENDRA Life Sciences Inc Earnings CallMarch 28, 2024 | businesswire.comENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 27, 2024 | benzinga.comEarnings Preview For ENDRA Life SciencesMarch 21, 2024 | finance.yahoo.comENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024March 14, 2024 | msn.comNuclera appoints Joseph Bertelsen as Chief Commercial OfficerMarch 6, 2024 | bizjournals.comLife sciences companies need more than just scientistsFebruary 28, 2024 | msn.comENDRA installs first TAEUS liver system at London hospitalFebruary 27, 2024 | finance.yahoo.comENDRA Life Sciences Installs First TAEUS System in the UKFebruary 27, 2024 | businesswire.comENDRA Life Sciences Installs First TAEUS System in the UKFebruary 23, 2024 | msn.comNew findings suggest life span can be increased by making cells less efficient at producing energyFebruary 21, 2024 | finance.yahoo.comNew ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS SystemFebruary 21, 2024 | businesswire.comNew ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences' TAEUS SystemFebruary 21, 2024 | investing.comENDRA Life Sciences Inc (NDRA)February 17, 2024 | investing.comENDRA Life Sciences secures new patents for ultrasound techFebruary 15, 2024 | wsj.comENDRA Life Sciences Inc.February 14, 2024 | businesswire.comENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and EuropeFebruary 9, 2024 | msn.comNirma Rs 1,343 crore open offer to buy more stake in Glenmark Life Sciences to start on Feb 15See More Headlines Receive NDRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ENDRA Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today5/09/2024Next Earnings (Confirmed)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:NDRA CUSIPN/A CIK1681682 Webwww.endrainc.com Phone(734) 335-0468FaxN/AEmployees21Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.93) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,060,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-197.36% Return on Assets-144.22% Debt Debt-to-Equity RatioN/A Current Ratio6.26 Quick Ratio3.36 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.67 per share Price / Book0.48Miscellaneous Outstanding Shares11,036,000Free Float10,506,000Market Cap$3.57 million OptionableNot Optionable Beta1.13 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Francois Michelon (Age 58)Chairman, President & CEO Comp: $423.59kMr. Michael Thornton Ph.D. (Age 56)Chief Technology Officer Comp: $301.67kDr. Jonathan Behr Ph.D.Co-FounderMs. Irina Pestrikova (Age 37)Senior Director of Finance & Secretary Mr. Steve FreemanHuman Resources LeaderKey CompetitorsNuwellisNASDAQ:NUWEHelius Medical TechnologiesNASDAQ:HSDTTivic Health SystemsNASDAQ:TIVCAethlon MedicalNASDAQ:AEMDKiromic BioPharmaNASDAQ:KRBPView All CompetitorsInsidersMichael Milos ThorntonBought 15,000 shares on 5/18/2023Total: $24,750.00 ($1.65/share)View All Insider Transactions NDRA Stock Analysis - Frequently Asked Questions How have NDRA shares performed in 2024? ENDRA Life Sciences' stock was trading at $2.12 at the beginning of 2024. Since then, NDRA shares have decreased by 84.8% and is now trading at $0.3231. View the best growth stocks for 2024 here. Are investors shorting ENDRA Life Sciences? ENDRA Life Sciences saw a decrease in short interest in April. As of April 15th, there was short interest totaling 7,600 shares, a decrease of 75.2% from the March 31st total of 30,600 shares. Based on an average daily trading volume, of 169,800 shares, the short-interest ratio is currently 0.0 days. Approximately 0.1% of the shares of the stock are short sold. View ENDRA Life Sciences' Short Interest. When is ENDRA Life Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our NDRA earnings forecast. How were ENDRA Life Sciences' earnings last quarter? ENDRA Life Sciences Inc. (NASDAQ:NDRA) issued its quarterly earnings results on Thursday, March, 28th. The company reported ($0.17) EPS for the quarter. What other stocks do shareholders of ENDRA Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other ENDRA Life Sciences investors own include Advanced Micro Devices (AMD), Trevena (TRVN), VBI Vaccines (VBIV), Bionano Genomics (BNGO), OPKO Health (OPK), TherapeuticsMD (TXMD), electroCore (ECOR) and Genocea Biosciences (GNCA). When did ENDRA Life Sciences IPO? ENDRA Life Sciences (NDRA) raised $10 million in an initial public offering on Friday, February 3rd 2017. The company issued 2,000,000 shares at a price of $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities acted as the underwriters for the IPO. How do I buy shares of ENDRA Life Sciences? Shares of NDRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NDRA) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchObama’s Forever Term [exposed]Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.